ATH alterity therapeutics limited

Funding good until well past Phase IIa results, proven results...

  1. 11,522 Posts.
    Funding good until well past Phase IIa results, proven results on using substituted 8-quinolinols for treatment of AD, exceptional metal chelation agents, PBT2 improvement on PBT1, then onto the possibility of treating Parkinsons and others.

    Looking to top up, good luck.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $91.27M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $1.235K 125K

Buyers (Bids)

No. Vol. Price($)
48 17502845 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 3340055 7
View Market Depth
Last trade - 10.00am 02/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.